TC99M generator and xenon radiopharmacueticals
Ended Purchase Order Awarded Last action
- Contract number
- W81K0025PA267
- Awardee
-
Lantheus Medical Imaging, Inc. UEI ZBTPKVDXCKJ7 Part of Lantheus Holdings, Inc.
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $63,682
Award facts
- Contract value 100% obligated
- $63,681.93 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- JBSA FT SAM HOUSTON, TX 78234, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $63,682 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
About this award
The Defense Health Agency awarded a $63,681.93 firm fixed-price purchase order to Lantheus Medical Imaging, Inc. for Technetium-99m (TC99M) generators and Xenon radiopharmaceuticals on October 1, 2025, with performance at JBSA Fort Sam Houston, Texas and a completion date of September 30, 2030. This contract was awarded without a small business set-aside designation. Lantheus Medical Imaging, a subsidiary of Lantheus Holdings, Inc., is a leading manufacturer of diagnostic nuclear medicine products headquartered in North Billerica, Massachusetts, and serves as a critical supplier of radiopharmaceutical agents and medical imaging equipment to federal healthcare facilities, including military treatment centers and Department of Veterans Affairs medical centers.
This purchase order supports the Defense Health Agency's medical imaging and diagnostic capabilities across its network of military treatment facilities. The award leverages Lantheus Medical Imaging's established expertise in nuclear medicine technologies and builds upon the company's substantial federal contracting relationship with the Defense Health Agency, including an existing $6.5 million blanket purchase agreement for diagnostic nuclear imaging supplies through July 2028. TC99M generators and xenon radiopharmaceuticals are essential diagnostic imaging agents used in nuclear medicine procedures throughout military healthcare systems, enabling efficient procurement of these specialized products through firm fixed-price arrangements that provide cost certainty for the federal healthcare system.
Quick answers
Who was awarded contract W81K0025PA267?
W81K0025PA267 was awarded to Lantheus Medical Imaging, Inc. by Medical Command (Department of the Army) on October 1, 2025.
How much is contract W81K0025PA267 worth?
The government has obligated $63,682 on W81K0025PA267.
Which agency awarded contract W81K0025PA267?
Medical Command (Department of the Army) awarded W81K0025PA267, with funding from Defense Health Agency (Department of Defense).
Was contract W81K0025PA267 competed?
The extent of competition for W81K0025PA267 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award